Elizabeth Trachtenberg Selected Research

Donor Selection

5/2014	Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.
10/2010	Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth Trachtenberg Research Topics

Disease

5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2009
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2012
2	Leukemia 05/2014 - 03/2009
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2013 - 10/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Otitis 10/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2012
1	Disease Susceptibility (Diathesis) 06/2012
1	Infections 03/2009

Drug/Important Bio-Agent (IBA)

4	KIR ReceptorsIBA 01/2022 - 11/2013
3	Peptides (Polypeptides)IBA 11/2013 - 03/2009
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2019
2	HLA-A Antigens (HLA-A)IBA 11/2013 - 10/2004
1	EnzymesIBA 01/2022
1	ArginaseIBA 01/2022
1	CytokinesIBA 01/2022
1	LigandsIBA 05/2014
1	HLA-C Antigens (HLA-C)IBA 05/2014
1	HLA-DPB1 antigen (HLA DPB1)IBA 10/2012
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2012
1	HLA-DP Antigens (HLA-DP)IBA 10/2012
1	Natural Killer Cell ReceptorsIBA 10/2010
1	AntigensIBA 03/2009
1	Proteins (Proteins, Gene)FDA Link 03/2009

Therapy/Procedure

3	Transplantation 01/2016 - 10/2010
2	Cell Transplantation 05/2014 - 01/2009
2	Donor Selection 05/2014 - 10/2010